Genomics

Dataset Information

ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [methylation 450K]


ABSTRACT: ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [methylation 450K]

PROVIDER: PRJNA548633 | ENA |

REPOSITORIES: ENA